Cita APA

Chen, R. C., Choueiri, T. K., Feuilly, M., Meng, J., Lister, J., Marteau, F., . . . Feldman, D. R. (2020). Quality‐adjusted survival with first‐line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance). Cancer.

Citación estilo Chicago

Chen, Ronald C., et al. "Quality‐adjusted Survival With First‐line Cabozantinib or Sunitinib for Advanced Renal Cell Carcinoma in the CABOSUN Randomized Clinical Trial (Alliance)." Cancer 2020.

Cita MLA

Chen, Ronald C., et al. "Quality‐adjusted Survival With First‐line Cabozantinib or Sunitinib for Advanced Renal Cell Carcinoma in the CABOSUN Randomized Clinical Trial (Alliance)." Cancer 2020.